Page 15 - Nasdaq Vktx News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq vktx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Vktx Today - Breaking & Trending Today

Viking Therapeutics (NASDAQ:VKTX) Price Target Increased to $32.00 by Analysts at Truist Financial

Viking Therapeutics (NASDAQ:VKTX – Get Rating) had its price objective lifted by Truist Financial from $28.00 to $32.00 in a research report report published on Wednesday, The Fly reports. Truist Financial currently has a buy rating on the biotechnology company’s stock. Several other analysts have also issued reports on the company. HC Wainwright reiterated a […] ....

San Diego , United States , Michaela Dinerman , Raymond James , Stifel Nicolaus , Marianna Mancini , Therapeutics Inc , Therapeutics Company Profile , Securities Exchange Commission , Virtu Financial , Cetera Advisor Networks , Asset Management Corp , Maxim Group , Viking Therapeutics , Get Rating , Truist Financial , Moderate Buy , Therapeutics Stock Down , Exchange Commission , Advisor Networks , Gate Manager , Management Corp , Brian Lian , Viking Therapeutics Daily , Nasdaq Vktx , Boost Price Target ,

Viking Therapeutics (NASDAQ:VKTX) PT Raised to $35.00

Viking Therapeutics (NASDAQ:VKTX – Get Rating) had its price objective lifted by Raymond James from $12.00 to $35.00 in a research report released on Wednesday, The Fly reports. The brokerage currently has an outperform rating on the biotechnology company’s stock. A number of other equities research analysts have also commented on VKTX. Stifel Nicolaus began […] ....

San Diego , United States , Raymond James , Michaela Dinerman , Marianna Mancini , Stifel Nicolaus , Therapeutics Inc , Securities Exchange Commission , Marshall Wace , Renaissance Technologies , Therapeutics Company Profile , Boxer Capital , Viking Therapeutics , Get Rating , Moderate Buy , Therapeutics Stock Down , Exchange Commission , Capital Management , Brian Lian , Viking Therapeutics Daily , Nasdaq Vktx , Boost Price Target ,

Legal & General Group's (LGEN) Equal Weight Rating Reaffirmed at Morgan Stanley

Viking Therapeutics (NASDAQ:VKTX – Get Rating) had its target price hoisted by Roth Mkm from $15.00 to $19.00 in a report published on Wednesday, Benzinga reports. The brokerage currently has a buy rating on the biotechnology company’s stock. Other equities research analysts also recently issued research reports about the stock. Oppenheimer lifted their price target […] ....

San Diego , United States , Michaela Dinerman , Roth Mkm , Raymond James , Stifel Nicolaus , Marianna Mancini , Maxim Group , Sg Americas Securities , Steward Partners Investment Advisory , Securities Exchange Commission , Therapeutics Company Profile , Brinker Capital Investments , Herr Investment Group , Therapeutics Inc , Viking Therapeutics , Get Rating , Moderate Buy , Therapeutics Stock Down , Exchange Commission , Capital Investments , Investment Group , Partners Investment Advisory , Centiva Capital , Brian Lian , Viking Therapeutics Daily ,

Viking Therapeutics (NASDAQ:VKTX) Price Target Raised to $31.00

Viking Therapeutics (NASDAQ:VKTX – Get Rating) had its target price raised by BTIG Research from $20.00 to $31.00 in a research report report published on Tuesday, The Fly reports. BTIG Research currently has a buy rating on the biotechnology company’s stock. Several other analysts have also recently commented on the stock. StockNews.com initiated coverage on […] ....

San Diego , United States , Michaela Dinerman , Raymond James , Marianna Mancini , Stifel Nicolaus , Renaissance Technologies , Therapeutics Inc , Marshall Wace , Boxer Capital , Viking Therapeutics , Get Rating , Moderate Buy , Capital Management , Brian Lian , Viking Therapeutics Daily , Nasdaq Vktx , Boost Price Target , Btig Research ,

Viking Therapeutics (NASDAQ:VKTX) PT Raised to $25.00 at Stifel Nicolaus

Viking Therapeutics (NASDAQ:VKTX – Get Rating) had its price target boosted by Stifel Nicolaus from $22.00 to $25.00 in a report issued on Tuesday morning, Benzinga reports. Stifel Nicolaus currently has a buy rating on the biotechnology company’s stock. VKTX has been the topic of a number of other research reports. Maxim Group boosted their […] ....

San Diego , United States , Stifel Nicolaus , Marianna Mancini , Michaela Dinerman , Boxer Capital , Maxim Group , Marshall Wace , Therapeutics Inc , Renaissance Technologies , Viking Therapeutics , Get Rating , Truist Financial , Moderate Buy , Therapeutics Stock Down , Capital Management , Brian Lian , Viking Therapeutics Daily , Nasdaq Vktx , Boost Price Target ,